Photo of Scott T. Benken

Scott T. Benken


Clinical Associate Professor, College of Pharmacy

Related Sites:

Teaching and Supervision

Undergrad Resrch Pharm Pract (PMPR 380), 8/23/2021 – 12/3/2021
PhLAMES 4 (PHAR 468), 1/11/2021 – 4/30/2021
Undergrad Resrch Pharm Pract (PMPR 380), 8/24/2020 – 12/4/2020
Undergrad Resrch Pharm Pract (PMPR 380), 1/13/2020 – 5/1/2020
Spec Project in Pharm Pract (PMPR 390), 1/13/2020 – 5/1/2020
Honors Seminar A decade of pharmacy experiences: From pharmacy student to pharmacist in the workplace (HON 201), 1/13/2020 – Present
Applied Research Methods and Skill Development (PMPR 385), 1/13/2020 – Present
Principles of Drug Action and Therapeutics (PHAR 510) (PHAR 510), 1/13/2020 – Present
Critical Care I (PMPR 430), 1/1/2020 – Present

Selected Grants

CTA: AST-134 Urine Sample Processing Study: Analysis of Fresh versus Frozen Urine Samples from ICU Subjects, Astute Medical., 11/9/2021 - 6/9/2023, Obligated Amount: $58138; Anticipated Amount: $58138

CTA: VDX 20-1001 Validation of genomic immune-phenotyping profiles in peripheral blood gene signatures to predict risk of kidney transplant rejection, Verici Dx., 5/4/2021 - 9/30/2024, Obligated Amount: $185844; Anticipated Amount: $185844

CTA: COVID19 M20-404 Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate Safety, Pharmacokinetics, & Pharmacodynamics of Single Ascending Doses of ABBV-47D11 in Adults..., AbbVie, Inc.., 4/12/2021 - 12/1/2021, Obligated Amount: $460435; Anticipated Amount: $460435

COVID19 Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP), Global Coalition for Adaptive Research., 3/1/2021 - 2/28/2022, Obligated Amount: $223052; Anticipated Amount: $223052

CTA: Evaluation of Patient Outcomes from the Kidneycare on Renal Allografts Registry (OKRA) Agreement, CareDX., 5/7/2020 - 5/7/2023, Obligated Amount: $297863; Anticipated Amount: $297863

Edoxaban Clearance during in vitro Continuous Renal Replacement Therapy, Daiichi Sankyo Inc., 3/1/2020 - 9/1/2020, Obligated Amount: $66354; Anticipated Amount: $66354

Edoxaban Clearance during in vitro Continuous Renal Replacement Therapy, Daiichi Sankyo Inc., 3/1/2020 - 9/1/2020, Obligated Amount: $66354; Anticipated Amount: $66354

Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients, Merck Sharp & Dohme Corp., 3/1/2020 - 7/31/2022, No Obligated Amount Set; Anticipated Amount: $137232.72

Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients, Merck Sharp & Dohme Corp., 3/1/2020 - 7/31/2022, No Obligated Amount Set; Anticipated Amount: $137232.72

Selected Publications

Andrews, Lauren, Benken, Jamie, Benedetti, Enrico, Nishioka, Hokuto, Dalton, Kaitlyn, Pierce, Dana, Han, Justin, Shin, Bona, Benken, Scott. (2021). 1327: ANGIOTENSIN II IN THE PERIOPERATIVE MANAGEMENT OF HYPOTENSION IN KIDNEY TRANSPLANT RECIPIENTS. Critical Care Medicine, 50, (1), 665-665. doi:10.1097/01.ccm.0000811632.85984.42.

Cucci, Michaelia, Cunningham, Brittany, Newey, Christopher, Benken, Scott, Mullen, Chanda. (2021). 1536: EVALUATION OF BLOOD PRESSURE VARIABILITY IN MODERATE TO SEVERE TRAUMATIC BRAIN INJURIES. Critical Care Medicine, 50, (1), 772-772. doi:10.1097/01.ccm.0000812468.82937.98.

Goldberg, Rachel N, Johns, Kevin, Ye, William, Mucksavage, Jeff J, Quigley, John G, Shapiro, Nancy L, Benken, Scott T, Atal, Neha, Jacobson, Jeffrey R, Kim, Keri S. (2021). Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center. Blood, 138, (Supplement 1), 1956-1956. doi:10.1182/blood-2021-150855.

Posen, Andrew, Benken, Scott, Kaluzna, Stephanie Dwyer, Sabouni, Murrah, Miglo, Jane, Cai, Jiaqi, Gimbar, Renee Petzel. (2021). Poor guideline adherence in a real-world evaluation of hypertensive emergency management. The American Journal of Emergency Medicine, 51, 46-52. doi:10.1016/j.ajem.2021.09.073.

Andrews, Lauren, Benken, Scott, Tan, Xing, Wenzler, Eric. (2021). Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy. BMC Nephrology, 22, (1), 45. doi:10.1186/s12882-021-02248-7.

Durst, Melissa M, Eitzen, Elizabeth A, Benken, Scott T. (2020). Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis. Annals of Pharmacotherapy, 55, (8), 970-979. doi:10.1177/1060028020980727.

Andrews, Lauren, Benken, Scott. (2020). 1261: Impact of Oral Midodrine on IV Vasopressor De-Escalation During Continuous Renal Replacement Therapy. Critical Care Medicine, 49, (1), 636-636. doi:10.1097/01.ccm.0000730932.66404.8c.

Dalton, Kaitlyn, Mucksavage, Jeffrey, Panlilio-Villanueva, Maria, Benken, Scott. (2020). 388: Comparison of End-Tidal CO2 Values in ICU Patients With and Without In-Hospital Cardiac Arrest. Critical Care Medicine, 49, (1), 183-183. doi:10.1097/01.ccm.0000727440.56731.48.

Andrews, Lauren, Benken, Scott, Tan, Xing, Wenzler, Eric. (2020). Pharmacokinetics and Dialytic Clearance of Apixaban During In Vitro Continuous Renal Replacement Therapy. . doi:10.21203/rs.3.rs-58735/v2.

Professional Leadership

Critical Care PRN Programming Committee, American College of Clinical Pharmacy, 12/1/2020 - Present

Critical Care Prep Course Planning Committee, American College of Clinical Pharmacy, 7/1/2020 - Present

American College of Clinical Pharmacy - Clinical Research Challenge Reviewer, American College of Clinical Pharmacy, 2/1/2018 - Present

Chicagoland Critical Care Conference, University of Illinois at Chicago College of Pharm, 12/1/2015 - Present

SCCM - Clinical Pharmacy and Pharmacology Section Communications Committee, Society of Critical Care Medicine, 1/1/2015 - Present

Notable Honors

2021, Student Preceptor of the Year (Class of 2021),

Education

Degrees:
Pharm.D., University of Cincinnati, United States, 2008
Pharmacy Prerequisite Coursework, Wake Forest University, United States, 2004

Postgraduate Training:
ASHP-Accredited PGY2 Residency in Critical Care Pharmacy, University of Illinois Hospital & Health Sciences System, United States, 2010
ASHP-Accredited PGY1 Pharmacy Practice Residency, University of Illinois Hospital & Health Sciences System, United States, 2009

Licensures and Certifications

Added Qualifications (AQ) – Cardiology, American Pharmacists Association, 4/1/2015 - Present
Board-Certified Pharmacotherapy Specialist, American Pharmacists Association, 12/1/2011 - Present
Advanced Cardiac Life Support, American Heart Association, 1/1/2008 - Present
Basic Life Support, American Heart Association, 1/1/2008 - Present

Selected Presentations

Gimbar, Renee, Dwyer, stephanie, Benken, sc, posen, drew. (2020 December 07). Evaluating Guideline Adherence in the Early Management of Hypertensive Emergency. ASHP Midyear Clinical Meeting. Virtual.